METTL26: A Protein Involved in Cell Proliferation, Death and Tissue Repair

Target Name: METTL26

NCBI ID: G84326

METTL26

METTL26: A Protein Involved in Cell Proliferation, Death and Tissue Repair

METTL26 (UPF0585 protein C16orf13) is a protein that is expressed in various tissues throughout the body. It is a member of the metal-尾-transcription factor-transcription factor (MET) family, which is known for its role in the regulation of gene expression. METTL26 has been shown to play a role in the development and progression of various diseases, including cancer. As a result, METTL26 has become a focus of interest for researchers looking for new potential drug targets or biomarkers.

One of the key features of METTL26 is its ability to interact with other proteins. This interaction is mediated by its unique protein structure, which is characterized by a long N-terminus and a N-cadherin-like domain. The N-terminus of METTL26 contains a putative transmembrane domain that is involved in its interactions with other proteins. This domain is known as the N-terminus domain (NTD) and is a common feature of many proteins that involve in cell signaling.

The NTD is responsible for several different functions, including the regulation of protein stability and the formation of protein-protein interactions. In addition, the NTD is involved in the regulation of cellular processes such as cell adhesion, migration, and the regulation of ion channels.

One of the most significant functions of METTL26 is its role in the regulation of cell proliferation. METTL26 has been shown to play a negative role in the regulation of cell proliferation, particularly in the regulation of cell cycle progression. This is done through its ability to interact with and inhibit the activity of the protein kinase PDK4.

PDK4 is a protein that is involved in the regulation of many different cellular processes, including cell growth, differentiation, and survival. It is a key regulator of the cell cycle, and is involved in the regulation of the association of the nuclear envelope with the cytoskeleton. In addition, PDK4 is involved in the regulation of cell adhesion, migration, and the regulation of ion channels.

METTL26 has been shown to interact with PDK4 and to inhibit its activity. This interaction between METTL26 and PDK4 has important implications for the regulation of cell proliferation and the development of cancer.

Another function of METTL26 is its role in the regulation of cell death. METTL26 has been shown to play a role in the regulation of cell death, particularly in the regulation of apoptosis. Apoptosis is a natural process that is involved in the regulation of cell life cycle, and is characterized by the cleavage of DNA by the enzyme caspase.

METTL26 has been shown to interact with the protein Bcl-2, which is involved in the regulation of apoptosis. Bcl-2 is a protein that is known for its ability to inhibit the activity of caspase, which is a key enzyme involved in the regulation of apoptosis. METTL26 has been shown to interact with Bcl-2 and to inhibit its activity, which has important implications for the regulation of cell death.

In addition to its role in the regulation of cell proliferation and cell death, METTL26 has also been shown to play a role in the regulation of tissue repair and regeneration. METTL26 is a transcription factor that is involved in the regulation of gene expression, and is known for its ability to interact with

Protein Name: Methyltransferase Like 26

The "METTL26 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about METTL26 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets